Ginkgo Bioworks Holdings Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $2.55 on 07/19/23, and the lowest price during the same period was recorded at $1.05 on 03/14/24.
52-week price history of DNA Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Ginkgo Bioworks Holdings Inc’s current trading price is -57.56% away from its 52-week high, while its distance from the 52-week low is 2.86%. The stock’s price range during this period has fluctuated between $1.05 and $2.55. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 41.7 million for the day, which was evidently higher than the average daily volume of 22.98 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Ginkgo Bioworks Holdings Inc (DNA) has experienced a quarterly decline of -25.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.19B and boasts a workforce of 1218 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4026, with a change in price of -0.4900. Similarly, Ginkgo Bioworks Holdings Inc recorded 22,060,453 in trading volume during the last 100 days, posting a change of -31.21%.
DNA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DNA stands at 0.22. Similarly, the long-term debt-to-equity ratio is also 0.20.
DNA Stock Stochastic Average
Ginkgo Bioworks Holdings Inc’s raw stochastic average for the past 50 days is currently at 5.36%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 5.36%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 5.16% and 7.71%, respectively.
DNA Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -36.09% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -44.90%. Over the past 30 days, the price of DNA has leaped by -27.52%. And in the last five days, it has fallen by -11.48%.
